Pharmacokinetics of vancomycin during continuous hemodiafiltration.

Details

Serval ID
serval:BIB_C209D356EB59
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Title
Pharmacokinetics of vancomycin during continuous hemodiafiltration.
Journal
Intensive care medicine
Author(s)
Santré C., Leroy O., Simon M., Georges H., Guery B., Beuscart C., Beaucaire G.
ISSN
0342-4642 (Print)
ISSN-L
0342-4642
Publication state
Published
Issued date
1993
Peer-reviewed
Oui
Volume
19
Number
6
Pages
347-350
Language
english
Notes
Publication types: Case Reports ; Journal Article
Publication Status: ppublish
Abstract
To study the pharmacokinetics of vancomycin in three patients with acute renal failure related to multi-organ failure during continuous venovenous hemodiafiltration (CVVHD).
Prospective exploratory, open-labelled study.
Critical Care Unit in a University Medical Centre.
3 patients exhibiting hemodynamic instability and oligo-anuric acute renal failure requiring extra-renal epuration were included in this study.
Every patient received 7.5 mg/kg IV vancomycin over 1 h for a documented or suspected nosocomial staphylococcal infection. Serum and dialysate outlets samples were collected before infusion and 1, 3, 6, 12, 18, 24 after the end of infusion.
Mean age was 58.7 years (range 41-79) and mean SAPS 15.7 (9-23). The mean peak concentrations were 27.3 mg/l (range 15.6-45.6) one hour after the end of infusion. The average remaining vancomycin concentration 24 h after the onset of infusion was 3.6 mg/l (range 2.6-4.5). The mean terminal disposition rate constant and elimination half-life were 0.05 h-1 and 13.9 h respectively. Mean total body clearance was 38.9 +/- 4.3 ml/min and dialysate outlet (DO) clearance 4.2 +/- 1.3 ml/min. The mean volume of distribution was 47.4 +/- 6.4 l.
CVVHD is effective for vancomycin elimination. In these patients, the elimination half-life is almost constant, involving a following injection of vancomycin 12 h later to achieve effective concentrations.
Keywords
Acute Kidney Injury/epidemiology, Acute Kidney Injury/metabolism, Acute Kidney Injury/therapy, Adult, Aged, Critical Illness, France/epidemiology, Half-Life, Hemodiafiltration/methods, Hemodiafiltration/statistics & numerical data, Hemodialysis Solutions/analysis, Humans, Male, Middle Aged, Prospective Studies, Time Factors, Vancomycin/analysis, Vancomycin/pharmacokinetics
Pubmed
Web of science
Create date
29/04/2021 9:59
Last modification date
17/07/2023 13:58
Usage data